Snapshot as of September 25, 2026. Updated every completed session.
MRNA is a large-cap Biotechnology company in the Healthcare sector. As of the PickWiseAI snapshot on September 25, 2026, it traded near $198.16, up 1.71% on the session. The screener’s macro trend rating is “Uptrend” with a trend-strength reading of “Very Strong”. Momentum: intraday RSI 42, macro RSI 76, which the model reads as overbought on the macro oscillator. The current reward-to-risk ratio is 0.06 against estimated downside risk of 6.32%. The model’s near-term forecast range is 197.32-198.34.
The information on this page is for research and educational purposes only. It is generated from public market data, may be delayed, and does not constitute investment advice or an offer to buy or sell any security. Trend, momentum and reward-to-risk readings are model outputs, not forecasts or recommendations. Past performance does not indicate future results.